Cidara Thera
(CDTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 26,107 | 10,379 | 40,744 | 6,216 | 7,109 |
| Gross Profit | 26,107 | 10,379 | 40,744 | 6,216 | 7,109 |
| Operating Expenses | 23,326 | 27,431 | 25,821 | 19,329 | 25,370 |
| Operating Income | 2,781 | -17,052 | 14,923 | -13,113 | -18,261 |
| Interest Expense | 0 | 0 | 0 | 0 | 20 |
| Other Income | 232 | 162 | 55 | -6 | 0 |
| Pre-tax Income | 3,013 | -16,890 | 14,978 | -13,119 | -18,281 |
| Net Income Continuous | 3,013 | -17,162 | 14,978 | -13,119 | -18,281 |
| Net Income | $3,013 | $-17,162 | $14,978 | $-13,119 | $-18,281 |
| EPS Basic Total Ops | 0.60 | -3.80 | 3.40 | -3.80 | -5.40 |
| EPS Basic Continuous Ops | 0.77 | -4.72 | 4.27 | -3.80 | -5.37 |
| EPS Diluted Total Ops | 0.60 | -3.80 | 3.40 | -3.80 | -5.40 |
| EPS Diluted Continuous Ops | 0.60 | -3.84 | 3.38 | -3.80 | -5.37 |
| EBITDA(a) | $3,288 | $-19,591 | $17,528 | $-13,333 | $-17,964 |